« Back to Record
Francque, S., Bedossa, P., Ratziu, V., Anstee, Q. Q., Bugianesi, E., Sanyal, A. J., Loomba, R., Harrison, S. S., Balabanska, R., Mateva, L., Lanthier, N., Alkhouri, N., Moreno, C., Schattenberg, J. M., Stefanova-Petrova, D., Vonghia, L., Rouzier, R., Guillaume, M., Hodge, A., Romero-Gómez, M., Huot-Marchand, P., Baudin, M., Richard, M. P., Abitbol, J.-L., Broqua, P., Junien, J. L., & Abdelmalek, M. M. (2021). A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH. The New England journal of medicine, 385(17), 1547-1558. doi:10.1056/NEJMoa2036205
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/336797



